Illinois

Showing 11-18 of 18 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Expanding the Therapeutic and Targeting Capacity of Lipid Nanoparticles for Beta-Cell Protection	The University of Chicago	Raghavendra Mirmira	Cures	01-September-2026 to 31-August-2028	$471,201.00
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation	The University of Chicago	Piotr Witkowski	Cures	01-February-2025 to 31-January-2027	$1,500,000.00
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation	The University of Chicago	Piotr Witkowski	Cures	01-February-2024 to 31-October-2026	$250,000.00
Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease.	The University of Chicago	Piotr Witkowski	Cures	01-September-2025 to 31-August-2029	$8,500,000.00
MDA5 and TRIM21 in β-cell inflammatory signaling and autoimmunity	The University of Chicago	Kerim Kaylan	Cures	01-July-2026 to 30-June-2028	$100,000.00
Development of β-Cell Targeted Lipid Nanoparticle Therapeutics	The University of Chicago	Jacob Ryan Enriquez	Cures	01-March-2025 to 29-February-2028	$247,790.00
Interferons and the Integrated Stress Response: Converging Pathways in β Cell Dysfunction in Type 1 Diabetes	The University of Chicago	Charanya Muralidharan	Cures	01-March-2026 to 28-February-2029	$285,000.00
Dissecting HLA Mechanisms in T1D, SLE, and MS Through High-Throughput Self-Antigen Profiling	The University of Chicago	Aly Khan	Cures	01-September-2025 to 31-August-2026	$150,000.00